SARS-CoV-2-IN-32

Cat. No.: IBDI-432024

SARS-CoV-2-IN-32 (compound 3g) is a COVID-19 inhibitor. SARS-CoV-2-IN-32 shows anti-proliferative activity against cancer cells. SARS-CoV-2-IN-32 exhibits comparatively high binding affinity (-8.8 Kcal/mole) to COVID-19 main protease (M pro) (PDB ID: 6LU7). SARS-CoV-2-IN-32 can be used in studies of cancer and COVID-19.

Product Details

Target	SARS-CoV
Molecular Weight	481.50
SMILES	[O-][N+](C1=CC=C(C(C2=C(N(C3=CC=CC=C3)N=C2C)O)C4=C(N(C5=CC=CC=C5)N=C4C)O)C=C1)=O

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.